Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (31-40 of 376) with videos related to

Pageof 38
Sort By:
European Urology Focus|July 21, 2017
Imaging for Prostate Cancer RecurrenceTobias Maurer, Matthias Eiber, Stefano Fanti, et al.
European Urology|January 24, 2017
A PET for All Seasons: <sup>18</sup>F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?Wolfgang P Fendler, Matthias Eiber, Christian G Stief, et al.
Clinical Nuclear Medicine|April 4, 2017
Image of the Month: Multifocal 68Ga Prostate-Specific Membrane Antigen Ligand Uptake in the Skeleton in a Man With Both Prostate Cancer and Multiple MyelomaIsabel Rauscher, Tobias Maurer, Katja Steiger, et al.
Medical Physics|October 7, 2019
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in <sup>177</sup> Lu-PSMA therapyAndreas Rinscheid, Peter Kletting, Matthias Eiber, et al.
EJNMMI Research|November 27, 2015
[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgeryMargret Schottelius, Martina Wirtz, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
RECIP 1.0: A Roadmap for Clinical ImplementationAndrei Gafita, Loic Djaileb, Jeremie Calais, et al.
Der Urologe. Ausg. A|February 9, 2022
[Prostate-specific membrane antigen positron emission tomography (PSMA PET) for urologists-when and which tracer?]Christoph Berliner, Claudia Kesch, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2021
2021: the year [<sup>177</sup>Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to "A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands" by Dr. Germo GerickeKen Herrmann, Clemens Kratochwil, Wolfgang P Fendler, et al.
EJNMMI Physics|June 20, 2020
Influence of sampling schedules on [<sup>177</sup>Lu]Lu-PSMA dosimetryAndreas Rinscheid, Peter Kletting, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2017
<sup>177</sup>Lu-PSMA Radioligand Therapy for Prostate CancerWolfgang P Fendler, Kambiz Rahbar, Ken Herrmann, et al.
Pageof 38

Showing results (31-40 of 376) with videos related to

Sort By:
Pageof 38
European Urology Focus|July 21, 2017
Imaging for Prostate Cancer RecurrenceTobias Maurer, Matthias Eiber, Stefano Fanti, et al.
European Urology|January 24, 2017
A PET for All Seasons: <sup>18</sup>F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?Wolfgang P Fendler, Matthias Eiber, Christian G Stief, et al.
Clinical Nuclear Medicine|April 4, 2017
Image of the Month: Multifocal 68Ga Prostate-Specific Membrane Antigen Ligand Uptake in the Skeleton in a Man With Both Prostate Cancer and Multiple MyelomaIsabel Rauscher, Tobias Maurer, Katja Steiger, et al.
Medical Physics|October 7, 2019
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in <sup>177</sup> Lu-PSMA therapyAndreas Rinscheid, Peter Kletting, Matthias Eiber, et al.
EJNMMI Research|November 27, 2015
[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgeryMargret Schottelius, Martina Wirtz, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
RECIP 1.0: A Roadmap for Clinical ImplementationAndrei Gafita, Loic Djaileb, Jeremie Calais, et al.
Der Urologe. Ausg. A|February 9, 2022
[Prostate-specific membrane antigen positron emission tomography (PSMA PET) for urologists-when and which tracer?]Christoph Berliner, Claudia Kesch, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2021
2021: the year [<sup>177</sup>Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to "A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands" by Dr. Germo GerickeKen Herrmann, Clemens Kratochwil, Wolfgang P Fendler, et al.
EJNMMI Physics|June 20, 2020
Influence of sampling schedules on [<sup>177</sup>Lu]Lu-PSMA dosimetryAndreas Rinscheid, Peter Kletting, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2017
<sup>177</sup>Lu-PSMA Radioligand Therapy for Prostate CancerWolfgang P Fendler, Kambiz Rahbar, Ken Herrmann, et al.
Pageof 38